Dianalitics
DXC Technology Company
DXC · v1 · 2026-08-24
hourglass
Loading…
Preparing the latest DD data, styles and content.
59NeutralDD: Aug 24, 2026Analyst: 57
paidPrice at analysis date
USD 10.8 (24/08/2026)
domainMkt cap
$1.73B
pie_chartShares
159.78M
candlestick_chart52W
$7.90-$15.68
trending_downShort interest
17.97%
MEDIUMNYSEInformation Technology115000 employeesFounded 1959
Verdict:

Favorable Risk/Reward - a levered IT-services turnaround where cash flow, repurchases and a cleaned-up litigation balance sheet create upside, but the market is right to demand proof that organic revenue decline has bottomed.

DIANALITICS RESEARCH INDEX
Score /100 - updated 2026-08-24
57
DXC Technology Company
Distressed cash-flow value: strong FCF and buyback, offset by revenue erosion, leverage and execution risk.
Fin. strength
11
/20 pts
EBITDA/FCF
12
/15 pts
Debt/leverage
8
/15 pts
Stage/business
9
/15 pts
Catalysts
6
/10 pts
Reg. risk
6
/8 pts
Risk/reward
5
/7 pts
Management
3
/5 pts
Sector/macro
2
/3 pts
Compliance
1
/2 pts
Fair value - segment EV bridge, not a simple analyst-target anchor
Fair value base case
USD 17.5
Range: USD 8.50-USD 24.0
Price at analysis date: USD 10.8 (24/08/2026)
Base upside/downside: +62%

Base-case implied EV is about $4.34B, equal to ~5.5x FY27 adjusted EBIT at the midpoint of revenue and margin guidance. Cross-check: $471M normalized FCF (FY27 guide $685M less $214M litigation cash) at 6.0x equals ~$17.7/sh after net debt, within 1% of the segment bridge. Sensitivity: each 1.0x turn of EBIT multiple moves FV by about $5/sh. Not investment advice.

ComponentAssumptionUSD/share
CES segment value$1.231B Q1 revenue x4 = ~$4.92B FY run-rate; 8.0% EBIT margin x 6.0x EV/EBIT+14.78
GIS turnaround value$1.449B Q1 revenue x4 = ~$5.80B; base recovery to 5.0% EBIT margin x 4.5x EV/EBIT+8.17
Insurance software / BPS$319M Q1 revenue x4 = ~$1.28B; 10.7% segment margin x 8.0x EV/EBIT+6.86
Net debt($501M short-term debt + $3.003B long-term debt - $1.957B cash) / 159.78M shares-9.68
Repurchase accretion option50% probability x ~$125M residual FY repurchases at ~$10.80 vs $17.50 base value+0.60
Execution / restructuring reserve~$510M equity haircut / 159.78M shares for GIS margin miss, organic decline and restructuring charges-3.23
FV base caseExplicit sum of the rows above: 14.78 + 8.17 + 6.86 - 9.68 + 0.60 - 3.2317.50
Bull
$22-$24
Probability: 25%
GIS stabilizes, book-to-bill exceeds 1.0x, FY27 FCF ex-litigation holds above $500M and short interest compresses.
Base
$17-$18
Probability: 45%
Revenue still declines, but segment profit and cash conversion support 5.5-6.0x normalized EBIT/FCF.
Bear
$8-$9
Probability: 30%
GIS margin remains near Q1 levels, bookings fail to recover and leverage absorbs the FCF case.
Methodology: Base-case implied EV is about $4.34B, equal to ~5.5x FY27 adjusted EBIT at the midpoint of revenue and margin guidance. Cross-check: $471M normalized FCF (FY27 guide $685M less $214M litigation cash) at 6.0x equals ~$17.7/sh after net debt, within 1% of the segment bridge. Sensitivity: each 1.0x turn of EBIT multiple moves FV by about $5/sh. Not investment advice. Not investment advice.
warning
High short interest and revenue-decline setup
The opportunity is not a quality compounder. July 2026 short interest was about 18% of float, Q1 FY27 organic revenue fell 6.7%, and GIS margins compressed sharply. The dislocation only works if bookings, GIS stabilization and cash conversion offset the shrinking top line.
Capital Structure - Short Interest - Repurchase & Dilution
Red - Short Interest
17.97%
28.39M shares short at July 31, 2026; 6.4 days to cover. This is high enough to amplify any guidance beat.
Green - Share count change
-6.18%
Shares outstanding fell to 159.78M, helped by $250M FY26 and $70M Q1 FY27 repurchases.
Green - Repurchase
$70M
Q1 FY27 repurchase retired ~6.7M shares. Accretive only while FCF remains durable.
Short Interest - context
DXC - 18.0%
18.0%

The short base is rational: declining organic revenue, high debt and a low-quality one-time FCF boost. It is also a catalyst: a clean Q2 guide or visible GIS stabilization can force covering.

$Financial analysis - FY
Q1 FY27 revenue
$3.00B
-5.1% YoY; -6.7% organic
Adj. EBIT margin
5.0%
Down from 6.8% prior year
FY27 FCF guide
~$685M
~$471M normalized ex-litigation cash
Net debt
~$1.55B
Debt $3.50B less cash $1.96B
ItemFY2024FY2025FY2026FY2027EGuidance 2027
Revenue$13.67B$12.87B$12.64B$12.10-$12.35B-5% to -3% organic
Adjusted EBITN/D~$1.02B$970M~$734-$865M6.0%-7.0% margin
Free cash flowN/D~$687M$713M~$685MIncludes $214M TCS cash
Non-GAAP EPSN/D$3.43$3.23$2.40-$2.90Down YoY
Quarterly dynamics - last 5 quarters
MetricQ1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue ($M)3,159~3,180~3,1703,1302,999
Adj. EBIT margin %6.8%N/DN/D7.6%5.0%
Net income ($M)18N/DN/DGAAP loss126
Cash EOP ($M)1,792N/DN/D1,7371,957
account_tree

Business model - three-segment turnaround

An enterprise IT services franchise priced as structurally impaired
DXC runs large-scale application, infrastructure and insurance software/BPS contracts for enterprise and public-sector clients. The valuation problem is not lack of scale; it is whether management can convert AI/OASIS and operating simplification into bookings before GIS decline eats the FCF base.

Consulting & Engineering Services ~$4.9B FY27 run-rate (41% rev) yellow - stabilizing Application modernization and engineering. Q1 organic revenue down 3.0%, margin 8.1%; still the cleanest bridge to AI-led project demand. Global Infrastructure Services ~$5.8B FY27 run-rate (48% rev) red - turnaround gate Managed infrastructure and cloud operations. Q1 organic revenue down 11.1%, margin 2.6%; this is the key downside driver. Insurance Software & Services ~$1.3B FY27 run-rate (11% rev) green - niche asset Insurance platforms and BPS. Q1 revenue up 1.9%, margin 10.7%; TCS judgment reinforces IP value but bookings were soft.

gavel

Legal, regulatory and risk analysis

Organic revenue decline
High
FY27 guide still calls for a 5% to 3% organic decline. A cheap multiple is not enough if the revenue base keeps shrinking.
GIS margin compression
Critical
GIS segment profit margin fell to 2.6% in Q1 FY27. The base FV needs recovery toward 5%, not perfection.
Leverage
Moderate
Net debt is about $1.55B. FCF covers it, but lower EBIT would quickly reduce repurchase flexibility.
Short interest
High
About 18% of float is short. This validates skepticism and increases volatility around quarterly updates.
TCS litigation cash
Positive
DXC collected roughly $214M after the Supreme Court declined to disturb the ruling; the matter is otherwise closed.
Leadership execution
Moderate
Paul Taylor was named President on July 30, 2026. A clearer operating owner helps, but transition risk remains.
Insider signal
Positive
Public snapshots show CEO Raul Fernandez purchased about $500K of stock in 2026, while reported selling was modest.
Analyst skepticism
Moderate
Consensus target near $11-$12 remains far below this FV. That gap is a risk flag, not a reason to ignore the cash-flow math.
article

SWOT analysis

Strengths
  • +Large installed enterprise base and $12B+ revenue scale.
  • +Material FCF generation even after normalizing one-time litigation cash.
  • +Active repurchase at depressed valuation.
Weaknesses
  • Organic revenue decline is still the central issue.
  • GIS margins leave little room for execution misses.
  • High debt load versus equity market cap.
Opportunities
  • OASIS / AI orchestration can reframe the services story.
  • Short-covering potential if Q2 shows book-to-bill above 1.0x.
  • Insurance software IP has strategic value beyond reported segment margin.
Threats
  • !Large customers can delay transformation spending.
  • !Automation can cannibalize legacy infrastructure revenue.
  • !Consensus skepticism may persist until revenue turns.
article

Summary by assessment area

Valuation - favorable
  • Current EV/EBITDA near 3x and normalized FCF yield are too low if FY27 guide holds.
  • Base FV $17.50 is driven by segment EBIT, not sell-side targets.
Operations - fragile
  • CES is workable, Insurance is valuable, but GIS must recover from 2.6% margin.
  • Organic growth remains negative into FY27 guidance.
Risk - high
  • Debt, short interest and shrinking revenue make this unsuitable for low-volatility mandates.
  • Bear case remains near $8-$9 if FCF proves one-time-heavy.
Sources & Disclaimer

Sources: DXC Q1 FY2027 press release and SEC exhibit filed July 30, 2026 for revenue, segment profit, bookings, cash flow, guidance, balance sheet, debt, cash and repurchases; DXC FY2026 release for FY2026 revenue, adjusted EBIT, FCF and repurchase history; DXC June 2026 10-Q and DXC newsroom release for the TCS litigation judgment and collection; StockAnalysis statistics and forecast pages for shares outstanding, EV, valuation ratios, analyst target and short % cross-check; Investing.com historical data and StockAnalysis price history for the August 21, 2026 close; MarketBeat short-interest snapshot for July 31, 2026 FINRA short interest; MarketBeat, Trefis and SEC Form 4 pages for insider/governance checks; StockAnalysis, FinanceCharts and Trefis peer valuation snapshots for CTSH, EPAM, ACN and DXC. Market data - last verified close 2026-08-21: DXC $10.80, market cap ~$1.73B, 52W range $7.90-$15.68, 159.78M shares outstanding. Short interest: 17.97% float. This document is for informational purposes only and does not constitute financial or investment advice.